drugset / Trial / NCT02039115

Reduction in Symptomatic Esophageal Stricture Formation

NCT02039115

Phase 4 Terminated 3 enrolled AdventHealth
RandomizedParallel-groupTriple-blindPrevention

Summary

Complete endoscopic resection of early neoplastic Barrett's Esophagus (BE) is a curative procedure. However, a significant proportion of patients develop symptomatic esophageal strictures following Complete Barrett's Eradication (CBE), and this limits the technique, particularly for circumferential and longer segment disease. Oral steroid therapy may reduce stricture formation; thereby allowing CBE to be performed with minimal associated morbidity.

Timeline

Start
2014-03
Primary completion
2015-02
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisone Other / unclassified 20 mg Oral

Indications

No indication recorded.